Consistently, in human hepatocellular carcinoma tissues, TANs expressed abundantly CCL17 and CCL2, which could attract Tregs and macrophages, respectively, and depletion of neutrophils enhanced the sensitivity to sorafenib in mouse HCC models, as evidenced by reduced tumor growth [128]. Here, CCL17 is linked to hepatocellular carcinoma.